![](https://www.microbiometimes.com/wp-content/uploads/2023/06/shutterstock_1172561641-326x245.jpg)
Concerto Biosciences Announces Discovery Initiative to Combat Recurrent Vaginal Yeast Infections
Concerto Biosciences announced the launch of a discovery endeavor to develop a new microbial product for the treatment of vulvovaginal candidiasis (VVC), a vaginal yeast infection that adversely affects 75% of women at some point […]